We now have more than 15 years of experience in developing infection resistant materials for medical devices that release antibacterials in very sustained manner for long periods of time (over 100 days), protective clothing that actively neutralize chemical and biological agents, sorbents for trace heavy metal removal, catalysts and membranes for fuel cells. Our broad expertise ranges from sustained release, biocompatible, antimicrobial powder formulations that can be incorporated in most polymers and applied to most surfaces to polymeric and inorganic - organic nanostructured materials for a variety of applications in the fuel cell and environmental area.

Established in 1991, ICET Inc. has secured:

 * Over 20 + years of R&D Experience

* 11 Patents Total and 3 Patents Pending

ICET, Inc is meeting the emerging needs for chemical and biological protective materials by developing self-decontaminating clothing, masks and gloves. The Shakthi TM technology involves triple defense protection: biocidal surface that kills spores and microorganisms, and passive blocking of chemical and biological species.

ICET, Inc has a substantial history of innovation for most of today's major markets. We have done several projects for all branches of the Army, Navy, Environmental Protection Agency, Department of Energy and several with National Institutes of Health.

The core business of ICET, Inc is contract R&D, a service that provides valuable solutions and ideas for our customers to help them develop products and manufacturing methods to win in the marketplace. In addition ICET, Inc licenses its technologies and work with industrial partners. Several projects at ICET, Inc have resulted in the creation of new technologies. ICET, Inc. provides contract research and development services in the areas of biomedicine, energy and the environment.

ICET, Inc follows a multifaceted strategy for commercialization which includes technology licensing, strategic partnering or joint venturing with large companies; transferring technology to the industrial sector through development contracts with public and semi-public organizations; transferring technology to government through non-SBIR government contracts; and investor financing of spin-off companies to manufacture and sell specific products.

We maintain over 3000 sq. ft. of office and laboratories and have staff and experts in mechanical, electrochemical , microbiology, biomedical and chemical, materials scientists and engineers and support staff. We are capable of handling multiple small and large projects.

Phone: 781-769-6064
Fax: 781-762-8204
Email: This e-mail address is being protected from spambots, you need JavaScript enabled to view it
 

Spinoffs:

* FDA approved EpiFLOTM Transdermal Sustained Oxygen Therapy (TSOT), currently selling in the US and Canada.

A Proven breakthrough therapy -restoring regenerative wound healing capacity impaired by disease, trauma, or other factors

(www.ogenix.com).

* Iseam LLC with Cohesive Systems

Novel seam tape technologies with active and passive barrier properties

* IFG Inc, with Primrose Medical Inc -manufacturer of the antimicrobial Foley catheter accessory device trade marked FoleyGuardTM


Principals


Shantha Sarangapani, Ph.D, President

* Expert Developer of Technologies
* Catalysis, Sensors
* Novel Membranes
* Nanomaterials
* Over 12 years of Applied R&D at ICET
* MS George Town Univ.
* Ph.D. Case Western Reserve Univ.
* 11 Patents, and 3 Pending

Sarang Sarangapani, Ph.D., MBA, Exec. VP

* Expert Electrochemist and Developer of New Technologies in Fuel Cell Areas and Industrial Electrochemistry, Business Development
* Spin-off enterprise currently manufacturing an FDA approved oxygen based wound healing product, EpiFLoTM
* 10 Patents and Several Publications

Consultants and Business Advisory Team

Subbarao Yalla, MD

VA Hospital, Harvard Medical School
Chief of Urology, Boston

Mary Rose Sullivan Ph.D.,

Biomedical Expert
VA Hospital, Boston MA

Todd Emrick Ph.D.,

Professor Polymer Science Department
UMass, Amherst MA


Arand Vasudevan

Former Sales VP from EMC2, Business Development.


Peter McDavitt

Former Director of NASA Commercialization Center, MA.


Roger Drake

Retired VP, Baxter Corporation